Suchergebnisse - "Piramoon, Majid"

PubPharm (10)

1

Preventive Risk Assessment of Medication in Intensive Wards

enthalten in: International journal of preventive medicine | 2023

von Hayati, H. | Piramoon, M.

2

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans

enthalten in: Current medical mycology | 2022

von Vaseghi, N. | Piramoon, M. | Khojasteh, S. | +5

3

Radiolabeled nanobodies for tumor targeting : From bioengineering to imaging and therapy

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2021

von Piramoon, M. | Khodadust, F. | Hosseinimehr, S.

4

In vitro and in silico evaluation of P-glycoprotein inhibition through 99m Tc-methoxyisobutylisonitrile uptake

enthalten in: Chemical biology & drug design | 2019

von Hosseini Balef, S. | Piramoon, M. | Hosseinimehr, S. | +1

5

99m Tc-anti-epidermal growth factor receptor nanobody for tumor imaging

enthalten in: Chemical biology & drug design | 2017

von Piramoon, M. | Hosseinimehr, S. | Omidfar, K. | +2

6

The Past, Current Studies and Future of Organometallic 99mTc(CO)3 Labeled Peptides and Proteins

enthalten in: Current pharmaceutical design | 2016

von Piramoon, M. | Hosseinimehr, S.

7

Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells

enthalten in: Journal of drug targeting | 2015

von Noaparast, Z. | Hosseinimehr, S. | Piramoon, M. | +1

8

Tumor targeting with a99mTc-labeled AS1411 aptamer in prostate tumor cells

enthalten in: Journal of drug targeting | 2015

von Noaparast, Z. | Hosseinimehr, S. | Piramoon, M. | +1

9

Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells

enthalten in: Journal of drug targeting | 2015

von Noaparast, Z. | Hosseinimehr, S. | Piramoon, M. | +1

10

Preparation and utilization of microporous molecularly imprinted polymer for sustained release of tetracycline

enthalten in: Journal of applied polymer science | 2013

von Mirzaei, M. | Najafabadi, S. | Abdouss, M. | +4

1
[1]